-
1
-
-
62249168182
-
Acute myeloid leukaemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2)
-
In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, eds, 4th ed. Lyon, France: IARC Press
-
Arber DA, Vardiman JW, Brunning DR, Porwit A, Le Beau MM, Thiele J, et al. Acute myeloid leukaemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008, p110-8.
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
, pp. 110-118
-
-
Arber, D.A.1
Vardiman, J.W.2
Brunning, D.R.3
Porwit, A.4
Le Beau, M.M.5
Thiele, J.6
-
2
-
-
79961012609
-
Myelodysplastic syndrome With inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2) has a high risk for progression to acute myeoid leukemia
-
Cui W, Sun J, Cotta CV, Medeiros LJ, Lin P. Myelodysplastic syndrome With inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2) has a high risk for progression to acute myeoid leukemia. Am J Clin Pathol. 2011; 136(2): 282-8.
-
(2011)
Am J Clin Pathol
, vol.136
, Issue.2
, pp. 282-288
-
-
Cui, W.1
Sun, J.2
Cotta, C.V.3
Medeiros, L.J.4
Lin, P.5
-
3
-
-
36048977071
-
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3; 3) (q21; q26) positive AML
-
Weisser M, Haferlach C, Haferlach T, Schnittger S. Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3; 3) (q21; q26) positive AML. Leuk Lymphoma. 2007; 48(11): 2145-51.
-
(2007)
Leuk Lymphoma
, vol.48
, Issue.11
, pp. 2145-2151
-
-
Weisser, M.1
Haferlach, C.2
Haferlach, T.3
Schnittger, S.4
-
4
-
-
0032833342
-
3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: Biological and clinical features
-
Testoni N, Borsaru G, Martinelli G, Carboni C, Ruggeri D, Ottaviani E, et al. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica. 1999; 84(8): 690-4.
-
(1999)
Haematologica
, vol.84
, Issue.8
, pp. 690-694
-
-
Testoni, N.1
Borsaru, G.2
Martinelli, G.3
Carboni, C.4
Ruggeri, D.5
Ottaviani, E.6
-
5
-
-
77956247735
-
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2) and various other 3q abnormalities in acute myeloid leukemia
-
Lugthart S, Groschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL, et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010; 28(24): 3890-8.
-
(2010)
J Clin Oncol
, vol.28
, Issue.24
, pp. 3890-3898
-
-
Lugthart, S.1
Groschel, S.2
Beverloo, H.B.3
Kayser, S.4
Valk, P.J.5
van Zelderen-Bhola, S.L.6
-
6
-
-
79952194399
-
De novo acute myeloid leukemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2): A clinicopathologic and cytogenetic study of an entity recently added to the WHO classification
-
Sun J, Konoplev SN, Wang X, Cui W, Chen SS, Medeiros LJ, et al. De novo acute myeloid leukemia with inv(3)(q21q26. 2) or t(3; 3)(q21; q26. 2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification. Mod Pathol. 2011; 24(3): 384-9.
-
(2011)
Mod Pathol
, vol.24
, Issue.3
, pp. 384-389
-
-
Sun, J.1
Konoplev, S.N.2
Wang, X.3
Cui, W.4
Chen, S.S.5
Medeiros, L.J.6
-
7
-
-
79960973763
-
Risk stratification of intermediate-risk acute myeloid leukemia: Integrative analysis of a multitude of gene mutation and gene expression markers
-
Rockova V, Abbas S, Wouters BJ, Erpelinck CA, Beverloo HB, Delwel R, et al. Risk stratification of intermediate-risk acute myeloid leukemia: Integrative analysis of a multitude of gene mutation and gene expression markers. Blood. 2011; 118(4): 1069-76.
-
(2011)
Blood
, vol.118
, Issue.4
, pp. 1069-1076
-
-
Rockova, V.1
Abbas, S.2
Wouters, B.J.3
Erpelinck, C.A.4
Beverloo, H.B.5
Delwel, R.6
-
8
-
-
77951641594
-
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities
-
Groschel S, Lugthart S, Schlenk RF, Valk PJM, Eiwen K, Goudswaard C, et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J Clin Oncol. 2010; 28: 2101-7.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2101-2107
-
-
Groschel, S.1
Lugthart, S.2
Schlenk, R.F.3
Valk, P.J.M.4
Eiwen, K.5
Goudswaard, C.6
-
9
-
-
0030919163
-
Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies
-
Shi G, Weh H-J, Diihrsen U, Zeller W, Hossfeld DK. Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies. Cancer Genet Cytogenet. 1997; 96(1): 58-63.
-
(1997)
Cancer Genet Cytogenet
, vol.96
, Issue.1
, pp. 58-63
-
-
Shi, G.1
Weh, H.-J.2
Diihrsen, U.3
Zeller, W.4
Hossfeld, D.K.5
-
10
-
-
84858830672
-
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge
-
Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol. 2012; 30(8): 820-9.
-
(2012)
J Clin Oncol
, vol.30
, Issue.8
, pp. 820-829
-
-
Schanz, J.1
Tüchler, H.2
Solé, F.3
Mallo, M.4
Luño, E.5
Cervera, J.6
-
11
-
-
84866621729
-
Revised international prognostic scoring system for myelodysplastic syndromes
-
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012; 120(12): 2454-65.
-
(2012)
Blood
, vol.120
, Issue.12
, pp. 2454-2465
-
-
Greenberg, P.L.1
Tuechler, H.2
Schanz, J.3
Sanz, G.4
Garcia-Manero, G.5
Solé, F.6
-
12
-
-
84867229265
-
Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases
-
Haferlach C, Bacher U, Grossmann V, Schindela S, Zenger M, Kohlmann A, et al. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Genes Chrosomosomes Cancer. 2012; 51: 1079-85.
-
(2012)
Genes Chrosomosomes Cancer
, vol.51
, pp. 1079-1085
-
-
Haferlach, C.1
Bacher, U.2
Grossmann, V.3
Schindela, S.4
Zenger, M.5
Kohlmann, A.6
-
13
-
-
2642552304
-
Molecular Heterogeneity in AML/MDS Patients with 3q21q26 Rearrangements
-
Lahortiga I, Vazquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A, et al. Molecular Heterogeneity in AML/MDS Patients with 3q21q26 Rearrangements. Genes Chromosomes Cancer. 2004; 40(3): 179-89.
-
(2004)
Genes Chromosomes Cancer
, vol.40
, Issue.3
, pp. 179-189
-
-
Lahortiga, I.1
Vazquez, I.2
Agirre, X.3
Larrayoz, M.J.4
Vizmanos, J.L.5
Gozzetti, A.6
-
14
-
-
10744221858
-
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts
-
Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G, et al. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. Haematologica. 2003; 88(11): 1221-8.
-
(2003)
Haematologica
, vol.88
, Issue.11
, pp. 1221-1228
-
-
Martinelli, G.1
Ottaviani, E.2
Buonamici, S.3
Isidori, A.4
Borsaru, G.5
Visani, G.6
-
15
-
-
84864315640
-
Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis
-
Kataoka K, Kurokawa M. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Cancer Sci. 2012; 103(8): 1371-7.
-
(2012)
Cancer Sci
, vol.103
, Issue.8
, pp. 1371-1377
-
-
Kataoka, K.1
Kurokawa, M.2
-
16
-
-
34250677675
-
The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions
-
Wieser R. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene. 2007; 396(2): 346-57.
-
(2007)
Gene
, vol.396
, Issue.2
, pp. 346-357
-
-
Wieser, R.1
-
17
-
-
33644760289
-
EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements
-
Poppe B, Dastugue N, Vandesompele J, Cauwelier B, De Smet B, Yigit N, et al. EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements. Genes Chromosomes Cancer. 2006; 45(4): 349-56.
-
(2006)
Genes Chromosomes Cancer
, vol.45
, Issue.4
, pp. 349-356
-
-
Poppe, B.1
Dastugue, N.2
Vandesompele, J.3
Cauwelier, B.4
De Smet, B.5
Yigit, N.6
-
18
-
-
84880992553
-
The shortest isoform of C/EBP liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model
-
Watanabe-Okochi N, Yoshimi A, Sato I, Ikeda T, Kumano K, Taoka K, et al. The shortest isoform of C/EBP liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model. Blood. 2013; 121(20): 4142-55.
-
(2013)
Blood
, vol.121
, Issue.20
, pp. 4142-4155
-
-
Watanabe-Okochi, N.1
Yoshimi, A.2
Sato, I.3
Ikeda, T.4
Kumano, K.5
Taoka, K.6
-
19
-
-
77954533006
-
Evi-1 as a critical regulator of leukemic cells
-
Goyama S, Kurokawa M. Evi-1 as a critical regulator of leukemic cells. Int J Hematol. 2010; 91(5): 753-7.
-
(2010)
Int J Hematol
, vol.91
, Issue.5
, pp. 753-757
-
-
Goyama, S.1
Kurokawa, M.2
-
20
-
-
70349640956
-
Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
-
Konrad TA, Karger A, Hackl H, Schwarzinger I, Herbacek I, Wieser R. Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J Leukoc Biol. 2009; 86(4): 813-22.
-
(2009)
J Leukoc Biol
, vol.86
, Issue.4
, pp. 813-822
-
-
Konrad, T.A.1
Karger, A.2
Hackl, H.3
Schwarzinger, I.4
Herbacek, I.5
Wieser, R.6
-
21
-
-
85047694750
-
EVI1 induces myelodysplastic syndrome in mice
-
Buonamici S, Li D, Chi Y, Zhao R, Wang X, Brace L, et al. EVI1 induces myelodysplastic syndrome in mice. J Clin Invest. 2004; 114(5): 713-9.
-
(2004)
J Clin Invest
, vol.114
, Issue.5
, pp. 713-719
-
-
Buonamici, S.1
Li, D.2
Chi, Y.3
Zhao, R.4
Wang, X.5
Brace, L.6
-
22
-
-
76249131912
-
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
-
Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med. 2010; 16(2): 198-204.
-
(2010)
Nat Med
, vol.16
, Issue.2
, pp. 198-204
-
-
Stein, S.1
Ott, M.G.2
Schultze-Strasser, S.3
Jauch, A.4
Burwinkel, B.5
Kinner, A.6
-
23
-
-
0030897009
-
International scoring system for evaluating prognosis in myelodysplastic syndromes
-
Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997; 89 (6): 2079-88.
-
(1997)
Blood
, vol.89
, Issue.6
, pp. 2079-2088
-
-
Greenberg, P.1
Cox, C.2
LeBeau, M.M.3
Fenaux, P.4
Morel, P.5
Sanz, G.6
-
25
-
-
79751531643
-
Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype
-
Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia. 2011; 25(2): 266-70.
-
(2011)
Leukemia
, vol.25
, Issue.2
, pp. 266-270
-
-
Patnaik, M.M.1
Hanson, C.A.2
Hodnefield, J.M.3
Knudson, R.4
Van Dyke, D.L.5
Tefferi, A.6
-
26
-
-
79953878823
-
Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum
-
Breems DA, Löwenberg B. Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum. Hematologica. 2011; 96(4): 491-3.
-
(2011)
Hematologica
, vol.96
, Issue.4
, pp. 491-493
-
-
Breems, D.A.1
Löwenberg, B.2
-
27
-
-
78149432321
-
Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome
-
Gohring G, Michalova K, Beverloo HB, Betts D, Harbott J, Haas OA, et al. Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010; 116 (19): 3766-9.
-
(2010)
Blood
, vol.116
, Issue.19
, pp. 3766-3769
-
-
Gohring, G.1
Michalova, K.2
Beverloo, H.B.3
Betts, D.4
Harbott, J.5
Haas, O.A.6
-
28
-
-
0022383747
-
Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia
-
Bitter MA, Neilly ME, Le Beau MM, Pearson MG, Rowley JD. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood. 1985; 66(6): 1362-70.
-
(1985)
Blood
, vol.66
, Issue.6
, pp. 1362-1370
-
-
Bitter, M.A.1
Neilly, M.E.2
Le Beau, M.M.3
Pearson, M.G.4
Rowley, J.D.5
-
29
-
-
38949205918
-
Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1
-
Laricchia-Robbio L, Nucifora G. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis. 2008; 40(2): 141-7.
-
(2008)
Blood Cells Mol Dis
, vol.40
, Issue.2
, pp. 141-147
-
-
Laricchia-Robbio, L.1
Nucifora, G.2
-
30
-
-
27244460633
-
The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity
-
Kilbey A, Alzuherri H, McColl J, Calés C, Frampton J, Bartholomew C. The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity. Br J Haematol. 2005; 130(6): 902-11.
-
(2005)
Br J Haematol
, vol.130
, Issue.6
, pp. 902-911
-
-
Kilbey, A.1
Alzuherri, H.2
McColl, J.3
Calés, C.4
Frampton, J.5
Bartholomew, C.6
-
31
-
-
84862497497
-
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs
-
Bindels EM, Havermans K, Lugthart S, Erpelinck C, Wocjtowicz E, Krivtsov AV, et al. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. Blood. 2012; 119(24): 5838-49.
-
(2012)
Blood
, vol.119
, Issue.24
, pp. 5838-5849
-
-
Bindels, E.M.1
Havermans, K.2
Lugthart, S.3
Erpelinck, C.4
Wocjtowicz, E.5
Krivtsov, A.V.6
-
32
-
-
0030765385
-
Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy
-
Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. Blood. 1997; 90(8): 2969-77.
-
(1997)
Blood
, vol.90
, Issue.8
, pp. 2969-2977
-
-
Estey, E.1
Thall, P.2
Beran, M.3
Kantarjian, H.4
Pierce, S.5
Keating, M.6
-
33
-
-
0035060568
-
Realistic pathologic classification of acute myeloid leukemias
-
Arber DA. Realistic pathologic classification of acute myeloid leukemias. Am J Clin Pathol. 2001; 115(4): 552-60.
-
(2001)
Am J Clin Pathol
, vol.115
, Issue.4
, pp. 552-560
-
-
Arber, D.A.1
-
34
-
-
0028026968
-
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3; 3)(q21; q26)
-
Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig WD, et al. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3; 3)(q21; q26). Leukemia. 1994; 8(8): 1318-26.
-
(1994)
Leukemia
, vol.8
, Issue.8
, pp. 1318-1326
-
-
Fonatsch, C.1
Gudat, H.2
Lengfelder, E.3
Wandt, H.4
Silling-Engelhardt, G.5
Ludwig, W.D.6
-
35
-
-
77950069794
-
Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2)
-
Medeiros BC, Kohrt HE, Arber DA. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26. 2)/t(3; 3)(q21; q26. 2). Leuk Res. 2010; 34(5): 594-7.
-
(2010)
Leuk Res
, vol.34
, Issue.5
, pp. 594-597
-
-
Medeiros, B.C.1
Kohrt, H.E.2
Arber, D.A.3
-
36
-
-
79955814184
-
The inv(3)(q21q26)/t(3; 3)(q21; q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: A study in 39 cases of MDS or AML
-
Haferlach C, Bacher U, Haferlach T, Dicker F, Alpermann T, Kern W, et al. The inv(3)(q21q26)/t(3; 3)(q21; q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML. Leukemia. 2011; 25: 874-7.
-
(2011)
Leukemia
, vol.25
, pp. 874-877
-
-
Haferlach, C.1
Bacher, U.2
Haferlach, T.3
Dicker, F.4
Alpermann, T.5
Kern, W.6
-
37
-
-
84857711160
-
Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: A study on 824 cases with aberrant karyotype
-
Haferlach C, Alpermann T, Schnittger S, Kern W, Chromik J, Schmid C, et al. Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype. Blood. 2012; 119(9): 2122-5.
-
(2012)
Blood
, vol.119
, Issue.9
, pp. 2122-2125
-
-
Haferlach, C.1
Alpermann, T.2
Schnittger, S.3
Kern, W.4
Chromik, J.5
Schmid, C.6
-
38
-
-
38149052949
-
Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1
-
Yagyu S, Morimoto A, Kakazu N, Tamura S, Fujiki A, Nakase Y, et al. Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1. Cancer Genetics Cytogenetics. 2008; 180(2): 115-20.
-
(2008)
Cancer Genetics Cytogenetics
, vol.180
, Issue.2
, pp. 115-120
-
-
Yagyu, S.1
Morimoto, A.2
Kakazu, N.3
Tamura, S.4
Fujiki, A.5
Nakase, Y.6
|